Overview

Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol

Status:
Recruiting

Trial end date:
2021-12-14

Target enrollment:

Participant gender:

Summary

To explore the safety and efficacy of edaravone dexborneol for the treatment of acute ischemic stroke patients who received endovascular thrombectomy.

Phase:

Phase 2

Details

Lead Sponsor:

Hui-Sheng Chen

Treatments:

Edaravone